ABBV stock rallies 9% YTD as Skyrizi and Rinvoq offset Humira declines, but can its pipeline, neuroscience growth and Apogee ...

Rep. Alexandria Ocasio-Cortez (AOC) sharply criticised major pharmaceutical companies during a Health Subcommittee hearing, ...

With 10-year Treasuries near 4.62%, VYM's $94.6 billion portfolio faces a real test from risk-free yields, and two familiar ...

News and commentary from the world of gastroenterology and hepatology ...

AbbVie and Baxter both flashed the same bullish technical signal this month, but only one golden cross signals genuine ...

Most defensive stocks aren’t defensive anymore. The playbook that worked for decades has stopped working. That’s the case ...

I love technology stocks -- even before the artificial intelligence boom, I was a big fan of Alphabet, Microsoft, Nvidia, and ...

AbbVie, Enbridge, and Coca-Cola pay high dividends and are the types of stocks that investors can buy and forget about.

Teva and Samsung Bioepis have entered into a license and commercialization agreement for Opuviz (aflibercept), a biosimilar ...

Drug pricing matters, but pipelines matter even more.

InterDigital: Patent Battles and Big Profits from Standard Licenses Anyone who uses a cell phone or streams videos today ...

Johnson & Johnson is the easiest healthcare name to evaluate on the board heading into its July 15 earnings release, and the ...